casimersen

Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
Investors Business Daily
Tue, 08/25/20 - 10:00 pm
Sarepta Therapeutics
FDA
fast track
Duchenne Muscular Dystrophy
casimersen
Sarepta to seek speedy approval of third DMD drug
Biopharma Dive
Thu, 03/28/19 - 07:57 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
casimersen